Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provid... Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.765 | 29.3677204659 | 6.01 | 8.8128 | 5.3401 | 345636 | 6.93736101 | CS |
| 4 | -0.352 | -4.33124154054 | 8.127 | 9.3 | 5.3401 | 1005871 | 7.53332101 | CS |
| 12 | 3.725 | 91.975308642 | 4.05 | 14.67 | 2.118 | 28561891 | 8.76928751 | CS |
| 26 | -0.475 | -5.75757575758 | 8.25 | 14.67 | 2.118 | 14066873 | 8.79354554 | CS |
| 52 | -8.425 | -52.0061728395 | 16.2 | 30.9 | 2.118 | 7545590 | 9.38434265 | CS |
| 156 | -10648.225 | -99.9270364114 | 10656 | 25200 | 2.118 | 3408835 | 1122.65815897 | CS |
| 260 | -57376.225 | -99.9864509271 | 57384 | 61632 | 2.118 | 3463264 | 3065.96566939 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
